Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel/cisplatin alternating with paclitaxel/etoposide (TP/TE)
Open Access
- 2 May 2008
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 19 (9) , 1578-1583
Abstract
Objectives: To evaluate the efficacy and toxicity of paclitaxel and cisplatin alternating with paclitaxel and etoposide doublet regimen (TP/TE), for salvage of patients with high-risk gestational trophoblastic neoplasia (GTN). Patients and methods: Twenty-four patients with GTN received TP/TE. Sixteen had failed previous chemotherapy including six with cisplatin-based regimens (group A) and eight changed to TP/TE because of prior treatment-induced toxic effects (group B). Results: In group A, three patients (19%) achieved a complete response (CR) and five (31%) a partial response (PR). All CR and four PR patients remain alive with a median follow-up of 25 months (range 9–48). The eight patients failing TP/TE subsequently died. Thus, the overall survival of the 16 patients in group A was 44% (seven of 16), rising to 70% (seven of 10) if the six patients who had failed prior cisplatin-based chemotherapy were excluded. In group B, four patients were assessable for response (two CR, two PR) and six remain alive (median follow-up 19 months) giving an overall survival of 75%. TP/TE was well tolerated, with only one patient discontinuing therapy because of toxic effects. Conclusion: TP/TE is an effective, well-tolerated, salvage treatment for relapsed patients who are heavily pretreated for GTN. Further studies of this regimen are warranted.Keywords
Funding Information
- CR-UK
- Department of Health for their Experimental Cancer Medicine Centre to MJS (C37/A7283)
This publication has 18 references indexed in Scilit:
- Gestational trophoblastic neoplasia management: an updateCurrent Opinion in Oncology, 2007
- Treatment of metastatic gestational trophoblastic neoplasiaThe Lancet Oncology, 2007
- Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumoursBritish Journal of Cancer, 2004
- Successful treatment of mother and baby with metastatic choriocarcinomaInternational Journal of Gynecological Cancer, 2002
- Low-Risk Persistent Gestational Trophoblastic Disease: Outcome After Initial Treatment With Low-Dose Methotrexate and Folinic Acid From 1992 to 2000Journal of Clinical Oncology, 2002
- The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: Description and critical assessmentInternational Journal of Gynecological Cancer, 2001
- Choriocarcinoma and partial hydatidiform molesThe Lancet, 2000
- Etoposide and Cisplatin/Etoposide, Methotrexate, and Actinomycin D (EMA) Chemotherapy for Patients With High-Risk Gestational Trophoblastic Tumors Refractory to EMA/Cyclophosphamide and Vincristine Chemotherapy and Patients Presenting With Metastatic Placental Site Trophoblastic TumorsJournal of Clinical Oncology, 2000
- EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients.Journal of Clinical Oncology, 1997
- Treatment of Resistant Gestational Choriocarcinoma with Taxol: A Report of Two CasesGynecologic Oncology, 1996